{"hands_on_practices": [{"introduction": "Effective planning for reoperative parathyroid surgery often requires navigating conflicting or ambiguous results from various imaging modalities. Instead of relying on intuition alone, a surgeon can use Bayesian inference to formally update the likelihood of a specific diagnosis, such as single-gland versus multigland disease. This practice [@problem_id:4663223] will guide you through the application of Bayesian updating in odds form, a powerful tool for quantitatively synthesizing a pre-test probability with new evidence from diagnostic tests, each with its own known likelihood ratio, to arrive at a more robust posterior probability to guide the surgical strategy.", "problem": "A 58-year-old patient with persistent primary hyperparathyroidism after a prior parathyroid exploration is evaluated for reoperative surgery. In this reoperative cohort at a high-volume center, the pretest probability of single-gland disease (a solitary adenoma) is assessed from historical data to be $0.60$. The patient undergoes technetium-99m single photon emission computed tomography (SPECT) with computed tomography (CT) sestamibi imaging, which is interpreted as nonlocalizing (negative). Subsequently, a four-dimensional computed tomography (4D-CT) scan is interpreted as positive for a single candidate lesion.\n\nFor this reoperative cohort, the following test characteristics are established from validation studies:\n- For a negative sestamibi SPECT/CT result, the negative likelihood ratio is $LR^{-} = 0.75$ for the target condition of single-gland disease.\n- For a positive 4D-CT result, the positive likelihood ratio is $LR^{+} = 5.00$ for the target condition of single-gland disease.\n\nAssume conditional independence of the two imaging tests given disease status. Using Bayesian updating in odds form and taking the defined target condition to be the presence of single-gland disease (as opposed to multigland disease), compute the posterior probability of single-gland disease after both tests (negative sestamibi followed by positive 4D-CT). Express your final answer as a decimal and round to four significant figures.", "solution": "The problem is validated as scientifically grounded, well-posed, objective, and self-contained. It presents a standard application of Bayesian inference in a medical diagnostics context. All necessary data and assumptions are provided.\n\nThe problem requires the computation of the posterior probability of a patient having single-gland disease (SGD) after two diagnostic tests, given a pretest probability and the likelihood ratios for the specific test outcomes. The method specified is Bayesian updating in odds form.\n\nLet $D$ be the event that the patient has single-gland disease. The alternative is multigland disease, denoted by $D^c$.\nLet $T_1^-$ be the event of a negative sestamibi SPECT/CT result.\nLet $T_2^+$ be the event of a positive 4D-CT result.\n\nThe givens are:\nPretest probability of single-gland disease: $P(D) = 0.60$.\nNegative likelihood ratio for the sestamibi scan: $LR_1^{-} = 0.75$.\nPositive likelihood ratio for the 4D-CT scan: $LR_2^{+} = 5.00$.\n\nThe core formula for Bayesian updating in odds form is:\n$$ \\text{Posterior Odds} = \\text{Prior Odds} \\times \\text{Likelihood Ratio} $$\n\nFirst, we calculate the prior odds of having single-gland disease. The probability of not having a single-gland disease is $P(D^c) = 1 - P(D)$.\n$$ P(D^c) = 1 - 0.60 = 0.40 $$\nThe prior odds, denoted $\\text{Odds}_{\\text{prior}}$, are the ratio of the probability of the event occurring to the probability of it not occurring:\n$$ \\text{Odds}_{\\text{prior}} = \\frac{P(D)}{P(D^c)} = \\frac{0.60}{0.40} = 1.5 $$\n\nThe problem states that the two imaging tests are conditionally independent given the disease status. This critical assumption allows us to calculate the total likelihood ratio for the combined test results ($T_1^-$ and $T_2^+$) by multiplying the individual likelihood ratios:\n$$ LR_{\\text{total}} = P(\\text{Test results} | D) / P(\\text{Test results} | D^c) $$\n$$ LR_{\\text{total}} = \\frac{P(T_1^-, T_2^+ | D)}{P(T_1^-, T_2^+ | D^c)} $$\nBy conditional independence:\n$$ LR_{\\text{total}} = \\frac{P(T_1^- | D) P(T_2^+ | D)}{P(T_1^- | D^c) P(T_2^+ | D^c)} = \\left(\\frac{P(T_1^- | D)}{P(T_1^- | D^c)}\\right) \\times \\left(\\frac{P(T_2^+ | D)}{P(T_2^+ | D^c)}\\right) $$\n$$ LR_{\\text{total}} = LR_1^{-} \\times LR_2^{+} $$\nSubstituting the given values:\n$$ LR_{\\text{total}} = 0.75 \\times 5.00 = 3.75 $$\n\nNow, we can update the prior odds to get the posterior odds using the total likelihood ratio:\n$$ \\text{Odds}_{\\text{posterior}} = \\text{Odds}_{\\text{prior}} \\times LR_{\\text{total}} $$\n$$ \\text{Odds}_{\\text{posterior}} = 1.5 \\times 3.75 = 5.625 $$\n\nThe posterior odds represent the odds of the patient having single-gland disease after considering the results of both tests. To find the posterior probability, $P(D | T_1^-, T_2^+)$, we convert the posterior odds back to a probability using the formula:\n$$ P_{\\text{posterior}} = \\frac{\\text{Odds}_{\\text{posterior}}}{1 + \\text{Odds}_{\\text{posterior}}} $$\nSubstituting the calculated posterior odds:\n$$ P_{\\text{posterior}} = \\frac{5.625}{1 + 5.625} = \\frac{5.625}{6.625} $$\nPerforming the division:\n$$ P_{\\text{posterior}} \\approx 0.84905660377... $$\n\nThe problem requires the final answer to be rounded to four significant figures.\n$$ P_{\\text{posterior}} \\approx 0.8491 $$\nThus, the posterior probability of the patient having single-gland disease after a negative sestamibi SPECT/CT scan and a positive 4D-CT scan is approximately $0.8491$.", "answer": "$$\\boxed{0.8491}$$", "id": "4663223"}, {"introduction": "Intraoperative parathyroid hormone (ioPTH) monitoring is a key adjunct in parathyroid surgery, yet interpreting the data in real time—especially in complex reoperative cases—can be challenging. Rather than relying on simplified criteria, a deeper understanding of the underlying hormone clearance kinetics provides a more rigorous basis for decision-making. This exercise [@problem_id:4663148] challenges you to apply a first-principles kinetic model to ioPTH decay data, forcing a quantitative assessment of whether the observed decline is consistent with a surgical cure or indicative of residual hyperfunctioning tissue.", "problem": "A 58-year-old patient with persistent primary hyperparathyroidism after a prior focused left-sided parathyroidectomy presents for reoperative exploration. Preoperative serum calcium is 13.2 mg/dL. Estimated glomerular filtration rate is 85 mL/min/1.73 $m^2$ with no known hepatic disease. Intraoperative parathyroid hormone (PTH) monitoring is used. The highest baseline before excision is 240 pg/mL (pre-excision), with a pre-incision value of 220 pg/mL. A visibly enlarged left inferior parathyroid gland is excised en bloc. Post-excision PTH values are 170 pg/mL at 5 minutes and 130 pg/mL at 10 minutes. The neck is scarred from prior surgery, and there is concern for injury to the recurrent laryngeal nerve (RLN) with further dissection.\n\nUse a first-principles kinetic model of hormone clearance to decide the next operative step. Assume that, in patients with normal renal function, circulating PTH clearance follows approximately first-order kinetics with a biologic half-life in the range of 3 to 5 minutes. Immediately after removal of all hyperfunctioning tissue, residual secretion from suppressed normal glands is minimal over the first tens of minutes, and the circulating PTH concentration decays toward a low-normal baseline that you may conservatively approximate as 40 pg/mL. Do not assume any special intraoperative threshold rule; instead, reason from the kinetics and the provided patient factors (including the markedly elevated preoperative calcium).\n\nWhat is the most appropriate intraoperative decision?\n\nA. Proceed to bilateral exploration for additional hyperfunctioning tissue now, as the observed PTH decay is inconsistent with complete source removal even under slow clearance assumptions\n\nB. Wait an additional 10 minutes to obtain a 20-minute PTH value before deciding on further exploration, because the 10-minute drop is borderline in a patient with high calcium\n\nC. Conclude operative success and terminate the exploration, because a near-50% PTH drop at 10 minutes is sufficient regardless of preoperative severity\n\nD. Attribute the slow decline to impaired PTH clearance from renal dysfunction and avoid further exploration to minimize RLN risk\n\nE. Administer intravenous fluids and a loop diuretic to lower serum calcium intraoperatively and reassess PTH kinetics after 30 minutes before deciding on further exploration", "solution": "The user has provided a clinical scenario and tasked me with determining the next operative step based on a first-principles kinetic model of parathyroid hormone (PTH) clearance.\n\n### Part 1: Problem Statement Validation\n\n**Step 1: Extract Givens**\n-   **Patient Profile**: 58-year-old patient with persistent primary hyperparathyroidism after a prior focused left-sided parathyroidectomy.\n-   **Biochemical Data**:\n    -   Preoperative serum calcium: 13.2 mg/dL.\n    -   Estimated glomerular filtration rate (eGFR): 85 mL/min/1.73 $m^2$.\n-   **Intraoperative PTH Data**:\n    -   Highest baseline (pre-excision) concentration, $C_{initial}$: 240 pg/mL.\n    -   Pre-incision concentration: 220 pg/mL.\n    -   Post-excision concentration at $t=5$ minutes, $C(5)$: 170 pg/mL.\n    -   Post-excision concentration at $t=10$ minutes, $C(10)$: 130 pg/mL.\n-   **Kinetic Model Parameters**:\n    -   Kinetics: First-order.\n    -   Biologic half-life, $t_{1/2}$: range of 3 to 5 minutes for normal renal function.\n    -   Post-curative baseline PTH concentration, $C_{baseline}$: approximately 40 pg/mL.\n-   **Surgical Context**: Reoperative exploration, scarred neck, concern for recurrent laryngeal nerve (RLN) injury.\n-   **Constraint**: The decision must be based on reasoning from the kinetic model, not on standard threshold rules (e.g., Miami criterion).\n\n**Step 2: Validate Using Extracted Givens**\n-   **Scientific Grounding**: The problem is scientifically sound. It uses the established principle of first-order kinetics for PTH clearance, a well-accepted biological half-life range, and standard clinical data (calcium, PTH, eGFR). The scenario is a realistic and challenging case in endocrine surgery.\n-   **Well-Posed**: The problem is well-posed. It provides all necessary numerical values and model parameters ($C_{initial}$, $C(t)$, $t$, $t_{1/2}$ range, $C_{baseline}$) to construct and apply the kinetic model and arrive at a logical conclusion.\n-   **Objectivity**: The problem is stated objectively, using precise clinical and biochemical terminology. The explicit instruction to use a first-principles model promotes an objective, quantitative analysis over subjective clinical judgment or simple rule application.\n-   **Consistency and Completeness**: The data are consistent and sufficient for the task. The eGFR of 85 mL/min/1.73 $m^2$ justifies using the normal half-life range of 3 to 5 minutes.\n\n**Step 3: Verdict and Action**\nThe problem statement is valid. I will now proceed with the quantitative analysis.\n\n### Part 2: Derivation and Solution\n\nThe problem requires modeling the decay of PTH concentration after the presumed removal of all hyperfunctioning tissue. The decay follows first-order kinetics towards a non-zero baseline. The governing equation is:\n$$C(t) - C_{baseline} = (C_{initial} - C_{baseline}) e^{-kt}$$\nwhere $C(t)$ is the PTH concentration at time $t$ post-excision, $C_{initial}$ is the pre-excision baseline, $C_{baseline}$ is the final steady-state concentration after cure, and $k$ is the rate constant.\n\nThe rate constant $k$ is related to the half-life $t_{1/2}$ by:\n$$k = \\frac{\\ln(2)}{t_{1/2}}$$\n\nWe are given:\n-   $C_{initial} = 240 \\text{ pg/mL}$\n-   $C_{baseline} \\approx 40 \\text{ pg/mL}$\n-   $t_{1/2}$ is in the range $[3 \\text{ min}, 5 \\text{ min}]$\n\nThe initial concentration above baseline is $C_{initial} - C_{baseline} = 240 - 40 = 200 \\text{ pg/mL}$. The model for successful resection is therefore:\n$$C(t) = 40 + 200 e^{-kt}$$\n\nWe must check if the observed data, $C(5) = 170 \\text{ pg/mL}$ and $C(10) = 130 \\text{ pg/mL}$, are consistent with this model for any allowed half-life. We will calculate the predicted PTH concentrations for the two extremes of the given half-life range.\n\n**Case 1: Slowest Normal Clearance ($t_{1/2} = 5$ minutes)**\nThe rate constant is $k_{slow} = \\frac{\\ln(2)}{5} \\approx 0.1386 \\text{ min}^{-1}$.\nThe predicted PTH concentration at $t=10$ minutes is:\n$$C_{pred}(10) = 40 + 200 e^{-0.1386 \\times 10} = 40 + 200 e^{-1.386}$$\n$$C_{pred}(10) \\approx 40 + 200(0.25) = 40 + 50 = 90 \\text{ pg/mL}$$\n(Alternatively, $10$ minutes is two half-lives, so the concentration above baseline should drop to $(1/2)^2 = 1/4$ of its initial value: $200 \\times 1/4 = 50$. Total PTH = $40+50 = 90$ pg/mL).\n\n**Case 2: Fastest Normal Clearance ($t_{1/2} = 3$ minutes)**\nThe rate constant is $k_{fast} = \\frac{\\ln(2)}{3} \\approx 0.231 \\text{ min}^{-1}$.\nThe predicted PTH concentration at $t=10$ minutes is:\n$$C_{pred}(10) = 40 + 200 e^{-0.231 \\times 10} = 40 + 200 e^{-2.31}$$\n$$C_{pred}(10) \\approx 40 + 200(0.099) \\approx 40 + 19.8 = 59.8 \\text{ pg/mL}$$\n\nSo, if the surgery were curative, the PTH level at $10$ minutes should be in the range $[59.8, 90]$ pg/mL.\n\n**Comparison with Observed Data:**\nThe observed PTH concentration at $10$ minutes is $C(10) = 130 \\text{ pg/mL}$. This value is substantially higher than the upper bound of the predicted range ($90 \\text{ pg/mL}$). The decay is significantly slower than what would be expected even with the slowest plausible normal clearance.\n\nTo further quantify this, we can calculate the apparent half-life that would produce the observed $C(10) = 130 \\text{ pg/mL}$:\n$$130 = 40 + (240 - 40) e^{-k \\times 10}$$\n$$90 = 200 e^{-10k}$$\n$$e^{-10k} = \\frac{90}{200} = 0.45$$\n$$-10k = \\ln(0.45) \\approx -0.7985$$\n$$k \\approx 0.07985 \\text{ min}^{-1}$$\nThe implied half-life is:\n$$t_{1/2, apparent} = \\frac{\\ln(2)}{k} \\approx \\frac{0.693}{0.07985} \\approx 8.7 \\text{ minutes}$$\nAn apparent half-life of $8.7$ minutes is well outside the normal physiological range of $3-5$ minutes. Since the patient's renal function is normal, this slow decay cannot be attributed to impaired clearance. The only remaining explanation is a persistent, un-resected source of PTH, indicating multigland disease. Therefore, the operation is incomplete. The correct surgical step is to search for the remaining hyperfunctioning tissue.\n\n### Part 3: Option-by-Option Analysis\n\n**A. Proceed to bilateral exploration for additional hyperfunctioning tissue now, as the observed PTH decay is inconsistent with complete source removal even under slow clearance assumptions**\nThis statement is a direct conclusion of the kinetic analysis performed above. The observed PTH level of 130 pg/mL at 10 minutes is well above the maximum predicted level of 90 pg/mL for a curative resection, even assuming the slowest normal clearance rate ($t_{1/2} = 5$ min). This indicates residual disease, and the standard of care is to continue the exploration to achieve a cure.\n**Verdict: Correct**\n\n**B. Wait an additional 10 minutes to obtain a 20-minute PTH value before deciding on further exploration, because the 10-minute drop is borderline in a patient with high calcium**\nThe kinetic analysis shows the 10-minute result is not \"borderline\"; it is definitive evidence of failure. The observed value (130 pg/mL) is 40 pg/mL higher than the most generous prediction (90 pg/mL), a substantial discrepancy. Waiting another 10 minutes would only confirm the slow decay trend already established by the 5-minute and 10-minute data points and would unnecessarily prolong anesthesia time. The decision can and should be made now.\n**Verdict: Incorrect**\n\n**C. Conclude operative success and terminate the exploration, because a near-50% PTH drop at 10 minutes is sufficient regardless of preoperative severity**\nThis option relies on a simplistic percentage-drop rule, which the problem statement explicitly forbids. Furthermore, the first-principles analysis demonstrates that such a rule is misleading in this case. The percentage drop from the baseline of 240 pg/mL is $(240-130)/240 \\times 100\\% = 45.8\\%$. While this is \"near 50%\", the absolute remaining PTH level is too high, proving the operation is not yet successful. Terminating the exploration would result in persistent hyperparathyroidism.\n**Verdict: Incorrect**\n\n**D. Attribute the slow decline to impaired PTH clearance from renal dysfunction and avoid further exploration to minimize RLN risk**\nThis option is factually incorrect. The patient's eGFR is given as 85 mL/min/1.73 $m^2$, which indicates normal renal function for the purposes of PTH clearance. The prolonged apparent half-life cannot be attributed to renal dysfunction. While RLN risk in a reoperative field is a serious consideration, it does not justify knowingly leaving a patient with persistent disease when the biochemical evidence for surgical failure is unequivocal.\n**Verdict: Incorrect**\n\n**E. Administer intravenous fluids and a loop diuretic to lower serum calcium intraoperatively and reassess PTH kinetics after 30 minutes before deciding on further exploration**\nThis proposed action is inappropriate and counterproductive. The primary issue is the clearance of a large, pre-existing pool of PTH from an autonomous source, not a dynamic response to calcium. Attempting to lower serum calcium would, if anything, stimulate any remaining parathyroid tissue (normal and abnormal) to secrete more PTH, thus confounding the interpretation of decay kinetics. The current data are clear and sufficient to make a decision without such interventions.\n**Verdict: Incorrect**", "answer": "$$\\boxed{A}$$", "id": "4663148"}, {"introduction": "Quantifying the increased risk of complications is a fundamental aspect of patient counseling and quality assessment in reoperative thyroid surgery. While we know that reoperations carry a higher risk of recurrent laryngeal nerve (RLN) injury than primary procedures, it is crucial to understand how to model this risk based on the specific mix of cases and procedures performed. In this problem [@problem_id:4663198], you will apply the principles of absolute risk, relative risk, and the law of total probability to calculate the expected increase in RLN injury risk for a hypothetical high-volume reoperative program, a skill essential for informed consent and surgical outcomes analysis.", "problem": "A surgical outcomes research team is modeling the risk of recurrent laryngeal nerve (RLN) injury in reoperative thyroid surgery. For a primary thyroid operation, let the baseline absolute risk of RLN injury be $r_{0} = 0.012$ (expressed as a decimal). In the reoperative setting, published data provide relative risk ratios that multiply the baseline risk depending on the reoperation subtype and whether a central neck dissection is performed concurrently.\n\nAssume the following reoperative case mix for a high-volume endocrine surgery program over a defined period:\n- Ipsilateral re-explorations constitute a proportion $p_{i} = 0.55$ of reoperative cases. For these cases, the relative risk ratio is $RR_{i} = 4.2$ compared with primary operations.\n- Contralateral completion thyroidectomies constitute a proportion $p_{c} = 0.45$ of reoperative cases. For these cases, the relative risk ratio is $RR_{c} = 2.3$ compared with primary operations.\n\nIn addition, within each reoperative subtype, a fraction of cases receives a concurrent central neck dissection, which multiplicatively modifies the relative risk:\n- Among ipsilateral re-explorations, the fraction receiving dissection is $f_{i} = 0.30$, and the multiplicative factor is $m_{i} = 1.6$.\n- Among contralateral completions, the fraction receiving dissection is $f_{c} = 0.15$, and the multiplicative factor is $m_{c} = 1.4$.\n\nAssume the relative risk multipliers are independent of the baseline primary risk and combine multiplicatively, and assume that within each subtype, the occurrence of central neck dissection is independent of other patient-level factors in this model.\n\nUsing only the definitions of absolute risk, relative risk, and the law of total probability across mutually exclusive subgroups, compute the expected absolute increase in RLN injury risk when moving from a primary thyroid operation to the reoperative program described above. Express your final answer as a decimal (without a percentage sign) and round to four significant figures.", "solution": "The user has provided a problem that requires the calculation of the expected absolute increase in surgical risk based on a probabilistic model.\n\n### Step 1: Extract Givens\nLet us first list the data and definitions provided in the problem statement.\n-   Baseline absolute risk of recurrent laryngeal nerve (RLN) injury for a primary operation: $r_{0} = 0.012$.\n-   Proportion of reoperative cases that are ipsilateral re-explorations: $p_{i} = 0.55$.\n-   Relative risk ratio for ipsilateral re-explorations (compared to primary): $RR_{i} = 4.2$.\n-   Proportion of reoperative cases that are contralateral completion thyroidectomies: $p_{c} = 0.45$.\n-   Relative risk ratio for contralateral completions (compared to primary): $RR_{c} = 2.3$.\n-   Fraction of ipsilateral cases receiving concurrent central neck dissection: $f_{i} = 0.30$.\n-   Multiplicative factor on relative risk for dissection in ipsilateral cases: $m_{i} = 1.6$.\n-   Fraction of contralateral cases receiving concurrent central neck dissection: $f_{c} = 0.15$.\n-   Multiplicative factor on relative risk for dissection in contralateral cases: $m_{c} = 1.4$.\n\n### Step 2: Validate Using Extracted Givens\nThe problem is scientifically grounded in the principles of epidemiology and biostatistics, using standard concepts like absolute risk and relative risk. It is a well-posed mathematical problem with all necessary data provided for a unique solution. The proportions of the two main reoperative subtypes are consistent, as $p_{i} + p_{c} = 0.55 + 0.45 = 1.0$. The problem is expressed objectively and is free of scientific flaws, ambiguities, or contradictions. Therefore, the problem is deemed valid and a solution can be derived.\n\n### Step 3: Derivation of the Solution\nThe objective is to compute the expected absolute increase in RLN injury risk when moving from a primary operation to the described reoperative program. This increase, which we will denote as $\\Delta R$, is the difference between the average absolute risk in the reoperative program, $R_{\\text{reop}}$, and the baseline absolute risk of a primary operation, $r_{0}$.\n$$ \\Delta R = R_{\\text{reop}} - r_{0} $$\n\nThe reoperative program consists of two mutually exclusive and exhaustive subgroups: ipsilateral re-explorations (I) and contralateral completions (C). We can calculate the average risk for the reoperative program, $R_{\\text{reop}}$, using the law of total probability:\n$$ R_{\\text{reop}} = p_{i} \\cdot R_{i} + p_{c} \\cdot R_{c} $$\nwhere $R_{i}$ is the average absolute risk for an ipsilateral re-exploration, and $R_{c}$ is the average absolute risk for a contralateral completion.\n\nFirst, we determine the average absolute risk for the ipsilateral re-exploration subgroup, $R_{i}$. This subgroup itself is partitioned into cases with central neck dissection (D) and cases without (ND). The fraction of cases with dissection is $f_{i}$, and the fraction without is $1 - f_{i}$.\nThe absolute risk for an ipsilateral re-exploration *without* dissection is the baseline risk multiplied by the corresponding relative risk: $r_{0} \\cdot RR_{i}$.\nThe absolute risk for an ipsilateral re-exploration *with* dissection has an additional multiplicative factor, $m_{i}$: $r_{0} \\cdot RR_{i} \\cdot m_{i}$.\nUsing the law of total probability again for this subgroup:\n$$ R_{i} = (1 - f_{i}) \\cdot (r_{0} \\cdot RR_{i}) + f_{i} \\cdot (r_{0} \\cdot RR_{i} \\cdot m_{i}) $$\n$$ R_{i} = r_{0} \\cdot RR_{i} \\cdot (1 - f_{i} + f_{i} \\cdot m_{i}) $$\n\nSimilarly, for the contralateral completion subgroup, the average absolute risk $R_{c}$ is calculated based on the fraction with dissection, $f_{c}$, and the fraction without, $1 - f_{c}$.\nThe absolute risk for a contralateral completion *without* dissection is $r_{0} \\cdot RR_{c}$.\nThe absolute risk for a contralateral completion *with* dissection is $r_{0} \\cdot RR_{c} \\cdot m_{c}$.\n$$ R_{c} = (1 - f_{c}) \\cdot (r_{0} \\cdot RR_{c}) + f_{c} \\cdot (r_{0} \\cdot RR_{c} \\cdot m_{c}) $$\n$$ R_{c} = r_{0} \\cdot RR_{c} \\cdot (1 - f_{c} + f_{c} \\cdot m_{c}) $$\n\nNow we can substitute the expressions for $R_{i}$ and $R_{c}$ back into the equation for $R_{\\text{reop}}$:\n$$ R_{\\text{reop}} = p_{i} \\cdot [r_{0} \\cdot RR_{i} \\cdot (1 - f_{i} + f_{i} \\cdot m_{i})] + p_{c} \\cdot [r_{0} \\cdot RR_{c} \\cdot (1 - f_{c} + f_{c} \\cdot m_{c})] $$\nFactoring out the baseline risk $r_{0}$:\n$$ R_{\\text{reop}} = r_{0} \\cdot [p_{i} \\cdot RR_{i} \\cdot (1 - f_{i} + f_{i} \\cdot m_{i}) + p_{c} \\cdot RR_{c} \\cdot (1 - f_{c} + f_{c} \\cdot m_{c})] $$\nThe term in the square brackets is the average relative risk for the entire reoperative program, which we can call $RR_{\\text{reop}}$.\n$$ RR_{\\text{reop}} = p_{i} \\cdot RR_{i} \\cdot (1 - f_{i} + f_{i} \\cdot m_{i}) + p_{c} \\cdot RR_{c} \\cdot (1 - f_{c} + f_{c} \\cdot m_{c}) $$\n\nThe desired quantity is the absolute increase in risk, $\\Delta R$:\n$$ \\Delta R = R_{\\text{reop}} - r_{0} = r_{0} \\cdot RR_{\\text{reop}} - r_{0} = r_{0} \\cdot (RR_{\\text{reop}} - 1) $$\nNow, we substitute the numerical values.\nFirst, calculate the effective risk multipliers for dissection within each subgroup:\n-   Ipsilateral: $1 - f_{i} + f_{i} \\cdot m_{i} = 1 - 0.30 + 0.30 \\cdot 1.6 = 0.70 + 0.48 = 1.18$\n-   Contralateral: $1 - f_{c} + f_{c} \\cdot m_{c} = 1 - 0.15 + 0.15 \\cdot 1.4 = 0.85 + 0.21 = 1.06$\n\nNext, calculate the average relative risk for the program, $RR_{\\text{reop}}$:\n$$ RR_{\\text{reop}} = (0.55 \\cdot 4.2 \\cdot 1.18) + (0.45 \\cdot 2.3 \\cdot 1.06) $$\n$$ RR_{\\text{reop}} = (2.31 \\cdot 1.18) + (1.035 \\cdot 1.06) $$\n$$ RR_{\\text{reop}} = 2.7258 + 1.0971 $$\n$$ RR_{\\text{reop}} = 3.8229 $$\n\nFinally, calculate the absolute increase in risk, $\\Delta R$:\n$$ \\Delta R = r_{0} \\cdot (RR_{\\text{reop}} - 1) $$\n$$ \\Delta R = 0.012 \\cdot (3.8229 - 1) $$\n$$ \\Delta R = 0.012 \\cdot 2.8229 $$\n$$ \\Delta R = 0.0338748 $$\n\nThe problem requires the answer to be rounded to four significant figures. The first significant figure is the first non-zero digit, which is $3$. The next three are $3$, $8$, and $7$. The digit following the seventh is $4$, so we round down.\n$$ \\Delta R \\approx 0.03387 $$", "answer": "$$ \\boxed{0.03387} $$", "id": "4663198"}]}